Journals / Kocaeli Tıp Dergisi / 2021 / Cilt: 10 - Sayı: Ek 2

Investigation of the Functional Role of mir-1825 in Laryngeal Squamous Cell Carcinoma Hep-2 Cell Line

Larenks Yassı Hücreli Karsinoma Hep-2 hücre Hattında mir-1825'in Fonksiyonel Rolünün Araştırılması

Pages
95–100
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RESULTS: As a result of the studies, it was determined that the proliferation (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:INTRODUCTION: Laryngeal cancer (LCa) is one of the most commonly diagnosed head and neck cancers in the world.
📊
Key Findings & Data:The increase in the incidence of LCa in recent years reveals the need for an early and effective biomarker in the diagnosis of LCa cancer.
💡
Conclusion & Impact:RESULTS: As a result of the studies, it was determined that the proliferation (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

INTRODUCTION: Laryngeal cancer (LCa) is one of the most commonly diagnosed head and neck cancers in the world. The increase in the incidence of LCa in recent years reveals the need for an early and effective biomarker in the diagnosis of LCa cancer. In this study, we aimed to investigate the functional role of mir-1825 in Hep-2, the LCa cell line. METHODS: In the study, transfection efficiency of inhibitor mir-1825 in Hep-2 cell line was confirmed by Realtime PCR. Proliferation and migration effects of Hep-2 cells were performed with Xcelligence RTCA device, invasion capacity was performed by matrigel method, and apoptosis levels were measured by changes in caspase-3 levels. RESULTS: As a result of the studies, it was determined that the proliferation (p

Özet

GİRİŞ ve AMAÇ: Larenks yassı hücreli karsinoma, dünyada en sık tanısı konan baş boyun kanserlerindendir. Larenks yassı hücreli karsinoma'nın son yıllardaki insidansının artışı, bu kanserin tanısında erken ve etkili biyobelirteç ihtiyacını ortaya çıkarmaktadır. mikroRNA’ların kanser progresyonunda önemli rolleri bulunmaktadır. Bu çalışmada mir-1825’in larenks yassı hücreli karsinoma hücre hattı olan Hep-2’de fonksiyonel rolünün araştırılmasını amaçladık. YÖNTEM ve GEREÇLER: Çalışma kapsamında; Hep-2 hücre hattında inhibitör mir-1825’in transfeksiyon etkinliği Kantitatif Realtime PCR ile doğrulandı. Hep-2 hücrelerinin proliferasyon, migrasyon etkileri Xcelligence RTCA cihazı ile, invazyon kapasiteleri Matrigel yöntemi ile, apoptoz düzeyleri ise caspase-3 seviyelerinin değişimleri ile gerçekleştirildi. BULGULAR: Çalışmalar neticesinde mir-1825’in Hep-2 hücrelerine transfeksiyonu sonrası hücrelerin proliferasyon (p

🔖

Cite This Article

TANOĞLU, E. G. (2022). Investigation of the Functional Role of mir-1825 in Laryngeal Squamous Cell Carcinoma Hep-2 Cell Line. Kocaeli Tıp Dergisi, Cilt: 10 - Sayı: Ek 2, 95–100. https://ajindex.com/articles/574674

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Li M, Zhao X, Liu Y, An J, Xiao H, Wang C. Aberrant expression of CDK8 regulates the malignant phenotype and associated with poor prognosis in human laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2017;274(5):2205-13
  2. Yu D, Liu Y, Yang J, Jin C, Zhao X, Cheng J, et al. Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma. Cell Biochem Biophys. 2015;71(1):261-9
  3. Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145-64
  4. Guzel E, Okyay TM, Yalcinkaya B, Karacaoglu S, Gocmen M, Akcakuyu MH. Tumor suppressor and oncogenic role of long non-coding RNAs in cancer. North Clin Istanb. 2020;7(1):81-6
  5. Helferich AM, Brockmann SJ, Reinders J, Deshpande D, Holzmann K, Brenner D, et al. Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS. Cell Mol Life Sci. 2018;75(23):4301-19
  6. Yilmaz SS, Guzel E, Karatas OF, Yilmaz M, Creighton CJ, Ozen M. MiR-221 as a pre- and postoperative plasma biomarker for larynx cancer patients. Laryngoscope. 2015;125(12):E377-81
  7. Guzel E, Karatas OF, Semercioz A, Ekici S, Aykan S, Yentur S, et al. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer. Int J Cancer. 2015;136(4):875-9
  8. Wiemer EA. The role of microRNAs in cancer: no small matter. Eur J Cancer. 2007;43(10):1529-44
  9. Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, et al. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res. 2009;19(7):828-37
  10. Guan G, Zhang D, Zheng Y, Wen L, Yu D, Lu Y, et al. microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma. Int J Clin Exp Pathol. 2014;7(9):5683-91
  11. Xing W, Zeng C. A novel serum microRNA-based identification and classification biomarker of human glioma. Tumour Biol. 2017;39(5):1010428317705339
  12. Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47(D1):D155-D62
  13. Yang CW, Wang SF, Yang XL, Wang L, Niu L, Liu JX. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis. Medicine (Baltimore). 2018;97(7):e9738
  14. Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127-D31
  15. Takeuchi T, Kawasaki H, Luce A, Cossu AM, Misso G, Scrima M,